| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.982 | 0.002 | 0.982 | Vasodilator, coronary | 0.95 0.002 DBMET03220 0.939 0.002 DBMET03224 0.962 0.002 DBMET03227 0.925 0.002 DBMET03221 0.893 0.003 DBMET03222 0.893 0.003 DBMET03226 0.854 0.003 DBMET03223 | ||
| 0.881 | 0.003 | 0.881 | Vasodilator, peripheral | 0.812 0.004 DBMET03220 0.797 0.004 DBMET03224 0.878 0.003 DBMET03227 0.809 0.004 DBMET03221 0.718 0.005 DBMET03222 0.775 0.004 DBMET03226 0.696 0.006 DBMET03223 | ||
| 0.872 | 0.004 | 0.9 | Spasmolytic | 0.842 0.004 DBMET03220 0.727 0.005 DBMET03224 0.9 0.003 DBMET03227 0.872 0.004 DBMET03221 0.685 0.007 DBMET03222 0.746 0.005 DBMET03226 0.705 0.006 DBMET03223 | DBMET03227 | |
| 0.853 | 0.002 | 0.853 | Calcium channel blocker | 0.804 0.002 DBMET03220 0.686 0.003 DBMET03224 0.716 0.003 DBMET03227 0.645 0.003 DBMET03221 0.61 0.003 DBMET03222 0.583 0.004 DBMET03226 0.508 0.004 DBMET03223 | ||
| 0.837 | 0.004 | 0.837 | Platelet aggregation inhibitor | 0.802 0.004 DBMET03220 0.815 0.004 DBMET03224 0.815 0.004 DBMET03227 0.769 0.004 DBMET03221 0.765 0.004 DBMET03222 0.817 0.004 DBMET03226 0.763 0.004 DBMET03223 | ||
| 0.819 | 0.003 | 0.821 | Vasodilator | 0.796 0.003 DBMET03220 0.792 0.003 DBMET03224 0.821 0.003 DBMET03227 0.798 0.003 DBMET03221 0.772 0.003 DBMET03222 0.809 0.003 DBMET03226 0.784 0.003 DBMET03223 | DBMET03227 | |
| 0.735 | 0.001 | 0.735 | Calcium antagonist | 0.542 0.002 DBMET03220 0.495 0.003 DBMET03224 0.557 0.002 DBMET03227 0.335 0.004 DBMET03221 0.286 0.005 DBMET03222 0.334 0.004 DBMET03226 0.179 0.016 DBMET03223 | ||
| 0.716 | 0.005 | 0.716 | Cardiotonic | 0.683 0.005 DBMET03220 0.603 0.008 DBMET03224 0.708 0.005 DBMET03227 0.673 0.005 DBMET03221 0.562 0.01 DBMET03222 0.622 0.007 DBMET03226 0.576 0.009 DBMET03223 | ||
| 0.647 | 0.005 | 0.688 | Platelet antagonist | 0.589 0.007 DBMET03220 0.644 0.005 DBMET03224 0.661 0.005 DBMET03227 0.603 0.007 DBMET03221 0.582 0.008 DBMET03222 0.688 0.005 DBMET03226 0.618 0.006 DBMET03223 | DBMET03226 | |
| 0.611 | 0.002 | 0.611 | Calcium channel L-type blocker | 0.56 0.002 DBMET03220 0.332 0.004 DBMET03224 0.469 0.003 DBMET03227 0.417 0.003 DBMET03221 0.288 0.004 DBMET03222 0.246 0.004 DBMET03226 0.209 0.005 DBMET03223 | ||
| 0.567 | 0.02 | 0.62 | Antithrombotic | 0.541 0.024 DBMET03220 0.536 0.024 DBMET03224 0.62 0.014 DBMET03227 0.593 0.017 DBMET03221 0.5 0.029 DBMET03222 0.559 0.021 DBMET03226 0.532 0.025 DBMET03223 | DBMET03227 | |
| 0.526 | 0.004 | 0.526 | Platelet activating factor antagonist | 0.469 0.005 DBMET03220 0.354 0.007 DBMET03224 0.441 0.005 DBMET03227 0.387 0.006 DBMET03221 0.297 0.012 DBMET03222 0.309 0.01 DBMET03226 0.247 0.017 DBMET03223 | ||
| 0.513 | 0.004 | 0.513 | Calcium channel (voltage-sensitive) blocker | 0.474 0.004 DBMET03220 0.228 0.012 DBMET03224 0.335 0.005 DBMET03227 0.307 0.006 DBMET03221 0.208 0.015 DBMET03222 0.186 0.02 DBMET03226 0.17 0.025 DBMET03223 | ||
| 0.487 | 0.013 | 0.617 | Anticonvulsant | 0.422 0.019 DBMET03220 0.58 0.008 DBMET03224 0.474 0.014 DBMET03227 0.408 0.021 DBMET03221 0.509 0.012 DBMET03222 0.617 0.006 DBMET03226 0.551 0.009 DBMET03223 | DBMET03226 | |
| 0.515 | 0.054 | 0.515 | Caspase 9 stimulant | 0.464 0.076 DBMET03220 0.464 0.076 DBMET03224 0.493 0.063 DBMET03227 0.443 0.087 DBMET03221 0.413 0.103 DBMET03222 0.411 0.105 DBMET03226 0.357 0.14 DBMET03223 | ||
| 0.332 | 0.024 | 0.332 | P-glycoprotein inhibitor | 0.299 0.029 DBMET03220 0.18 0.08 DBMET03224 0.294 0.03 DBMET03227 0.267 0.036 DBMET03221 0.167 0.093 DBMET03222 0.155 0.11 DBMET03226 0.144 0.127 DBMET03223 | ||
| 0.315 | 0.036 | 0.337 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.143 DBMET03220 0.337 0.029 DBMET03224 0.315 0.036 DBMET03227 0.156 0.143 DBMET03221 0.17 0.123 DBMET03222 0.331 0.031 DBMET03226 0.166 0.127 DBMET03223 | DBMET03224 | |
| 0.285 | 0.025 | 0.384 | Diuretic | 0.23 0.035 DBMET03220 0.225 0.036 DBMET03224 0.384 0.014 DBMET03227 0.323 0.019 DBMET03221 0.186 0.05 DBMET03222 0.314 0.02 DBMET03226 0.269 0.028 DBMET03223 | DBMET03227 | |
| 0.271 | 0.02 | 0.318 | Acetylcholine M1 receptor antagonist | 0.24 0.028 DBMET03220 0.201 0.042 DBMET03224 0.318 0.011 DBMET03227 0.291 0.016 DBMET03221 0.175 0.055 DBMET03222 0.251 0.025 DBMET03226 0.223 0.033 DBMET03223 | DBMET03227 | |
| 0.278 | 0.05 | 0.299 | Gastrin inhibitor | 0.299 0.034 DBMET03220 0.227 0.109 DBMET03224 0.278 0.051 DBMET03227 0.298 0.034 DBMET03221 0.251 0.078 DBMET03222 0.235 0.097 DBMET03226 0.259 0.069 DBMET03223 | DBMET03220 | |
| 0.186 | 0.028 | 0.238 | Acetylcholine muscarinic antagonist | 0.149 0.044 DBMET03220 0.123 0.064 DBMET03224 0.238 0.017 DBMET03227 0.19 0.027 DBMET03221 0.098 0.093 DBMET03222 0.155 0.041 DBMET03226 0.125 0.062 DBMET03223 | DBMET03227 | |
| 0.158 | 0.009 | 0.158 | Phosphodiesterase III inhibitor | 0.144 0.011 DBMET03220 0.106 0.02 DBMET03224 0.133 0.012 DBMET03227 0.123 0.014 DBMET03221 0.099 0.023 DBMET03222 0.09 0.028 DBMET03226 0.085 0.032 DBMET03223 | ||
| 0.31 | 0.165 | 0.33 | Apoptosis agonist | 0.293 0.177 DBMET03220 0.33 0.152 DBMET03227 0.313 0.163 DBMET03221 | DBMET03227 | |
| 0.175 | 0.033 | 0.202 | DNA intercalator | 0.185 0.03 DBMET03224 0.182 0.031 DBMET03227 0.202 0.025 DBMET03226 0.091 0.084 DBMET03223 | DBMET03226 | |
| 0.146 | 0.025 | 0.41 | Estrogen antagonist | 0.133 0.034 DBMET03220 0.265 0.008 DBMET03224 0.244 0.009 DBMET03227 0.204 0.012 DBMET03221 0.219 0.011 DBMET03222 0.41 0.004 DBMET03226 0.338 0.005 DBMET03223 | DBMET03226 | |
| 0.164 | 0.043 | 0.164 | Anesthetic local | 0.117 0.069 DBMET03220 0.114 0.072 DBMET03224 0.155 0.047 DBMET03227 0.11 0.074 DBMET03221 0.109 0.076 DBMET03226 | ||
| 0.14 | 0.019 | 0.477 | Estrogen receptor beta antagonist | 0.127 0.025 DBMET03220 0.319 0.005 DBMET03224 0.255 0.006 DBMET03227 0.207 0.009 DBMET03221 0.259 0.006 DBMET03222 0.477 0.004 DBMET03226 0.407 0.004 DBMET03223 | DBMET03226 | |
| 0.122 | 0.003 | 0.122 | Benzodiazepine antagonist | 0.096 0.004 DBMET03220 0.064 0.01 DBMET03224 0.069 0.008 DBMET03227 0.059 0.014 DBMET03221 0.055 0.019 DBMET03222 0.051 0.024 DBMET03226 0.044 0.041 DBMET03223 | ||
| 0.238 | 0.136 | 0.355 | Transcription factor NF kappa B inhibitor | 0.28 0.106 DBMET03220 0.298 0.095 DBMET03227 0.355 0.075 DBMET03221 0.227 0.144 DBMET03222 0.205 0.164 DBMET03226 0.25 0.127 DBMET03223 | DBMET03221 | |
| 0.138 | 0.04 | 0.145 | Mucolytic | 0.133 0.044 DBMET03220 0.113 0.062 DBMET03224 0.145 0.035 DBMET03227 0.14 0.039 DBMET03221 0.108 0.067 DBMET03222 0.101 0.076 DBMET03226 0.097 0.082 DBMET03223 | DBMET03227 | |
| 0.247 | 0.157 | 0.378 | Histamine release inhibitor | 0.25 0.155 DBMET03220 0.266 0.144 DBMET03224 0.375 0.088 DBMET03227 0.378 0.087 DBMET03221 0.269 0.142 DBMET03222 0.343 0.103 DBMET03226 0.347 0.101 DBMET03223 | DBMET03221 | |
| 0.097 | 0.008 | 0.148 | Growth hormone secretagogue receptor agonist | 0.091 0.009 DBMET03220 0.143 0.004 DBMET03224 0.078 0.012 DBMET03227 0.07 0.014 DBMET03221 0.135 0.004 DBMET03222 0.148 0.004 DBMET03226 0.138 0.004 DBMET03223 | DBMET03226 | |
| 0.219 | 0.13 | 0.248 | Hypoxia-inducible factor 1 alpha inhibitor | 0.2 0.152 DBMET03220 0.248 0.103 DBMET03224 0.235 0.115 DBMET03227 0.215 0.135 DBMET03221 0.228 0.121 DBMET03222 0.232 0.117 DBMET03226 0.213 0.137 DBMET03223 | DBMET03224 | |
| 0.173 | 0.086 | 0.191 | Hepatoprotectant | 0.165 0.094 DBMET03220 0.159 0.101 DBMET03224 0.191 0.071 DBMET03227 0.182 0.078 DBMET03221 0.149 0.11 DBMET03222 0.166 0.094 DBMET03226 0.156 0.104 DBMET03223 | DBMET03227 | |
| 0.142 | 0.057 | 0.174 | Cholinergic antagonist | 0.12 0.074 DBMET03220 0.174 0.04 DBMET03227 0.149 0.053 DBMET03221 0.104 0.09 DBMET03226 | DBMET03227 | |
| 0.147 | 0.067 | 0.219 | Adenylate cyclase stimulant | 0.174 0.031 DBMET03220 0.138 0.085 DBMET03224 0.188 0.02 DBMET03227 0.219 0.007 DBMET03221 0.164 0.042 DBMET03222 0.164 0.043 DBMET03226 0.191 0.018 DBMET03223 | DBMET03221 | |
| 0.22 | 0.143 | 0.22 | Caspase 3 stimulant | 0.213 0.15 DBMET03220 0.193 0.179 DBMET03224 0.214 0.15 DBMET03227 0.208 0.158 DBMET03221 0.189 0.187 DBMET03222 | ||
| 0.134 | 0.059 | 0.165 | Acetylcholine antagonist | 0.113 0.077 DBMET03220 0.165 0.043 DBMET03227 0.14 0.056 DBMET03221 0.099 0.093 DBMET03226 | DBMET03227 | |
| 0.078 | 0.004 | 0.078 | Benzodiazepine receptor peripheral-type antagonist | 0.068 0.004 DBMET03220 0.065 0.005 DBMET03224 0.069 0.004 DBMET03227 0.06 0.005 DBMET03221 0.056 0.005 DBMET03222 0.063 0.005 DBMET03226 0.054 0.005 DBMET03223 | ||
| 0.124 | 0.053 | 0.136 | Photosensitizer | 0.099 0.091 DBMET03224 0.136 0.04 DBMET03227 0.104 0.082 DBMET03226 | DBMET03227 | |
| 0.117 | 0.049 | 0.135 | Butyrylcholinesterase inhibitor | 0.094 0.066 DBMET03220 0.135 0.04 DBMET03224 0.094 0.067 DBMET03227 0.107 0.056 DBMET03222 0.123 0.045 DBMET03226 0.096 0.065 DBMET03223 | DBMET03224 | |
| 0.179 | 0.117 | 0.514 | Aldehyde oxidase inhibitor | 0.417 0.045 DBMET03224 0.314 0.063 DBMET03227 0.161 0.129 DBMET03222 0.514 0.031 DBMET03226 0.213 0.098 DBMET03223 | DBMET03226 | |
| 0.081 | 0.027 | 0.087 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 DBMET03220 0.087 0.022 DBMET03224 0.067 0.046 DBMET03227 0.062 0.057 DBMET03221 0.079 0.029 DBMET03222 0.075 0.033 DBMET03226 0.069 0.042 DBMET03223 | DBMET03224 | |
| 0.136 | 0.089 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET03227 0.141 0.068 DBMET03221 0.134 0.099 DBMET03226 | DBMET03227 | |
| 0.157 | 0.11 | 0.197 | Psychostimulant | 0.185 0.089 DBMET03220 0.169 0.101 DBMET03227 0.197 0.082 DBMET03221 0.141 0.124 DBMET03223 | DBMET03221 | |
| 0.104 | 0.064 | 0.111 | Expectorant | 0.106 0.063 DBMET03220 0.11 0.058 DBMET03227 0.111 0.057 DBMET03221 | DBMET03221 | |
| 0.103 | 0.067 | 0.138 | Topoisomerase I inhibitor | 0.116 0.058 DBMET03224 0.135 0.048 DBMET03227 0.138 0.046 DBMET03226 | DBMET03226 | |
| 0.095 | 0.065 | 0.155 | Sphingomyelinase inhibitor | 0.155 0.023 DBMET03224 0.119 0.042 DBMET03222 0.107 0.052 DBMET03226 | DBMET03224 | |
| 0.169 | 0.146 | 0.174 | DNA damaging | 0.174 0.141 DBMET03227 | DBMET03227 | |
| 0.033 | 0.014 | 0.036 | Thiazolidinedione | 0.032 0.016 DBMET03220 0.036 0.011 DBMET03224 0.03 0.02 DBMET03227 0.029 0.023 DBMET03221 0.034 0.013 DBMET03222 0.033 0.014 DBMET03226 0.031 0.016 DBMET03223 | DBMET03224 | |
| 0.094 | 0.077 | 0.121 | Mediator release inhibitor | 0.121 0.047 DBMET03227 0.108 0.06 DBMET03221 0.091 0.08 DBMET03226 | DBMET03227 | |
| 0.025 | 0.012 | 0.025 | Elastase 2A inhibitor | 0.024 0.013 DBMET03220 | ||
| 0.025 | 0.012 | 0.025 | Elastase 2 inhibitor | 0.024 0.013 DBMET03220 | ||
| 0.142 | 0.129 | 0.142 | Antimitotic | |||
| 0.065 | 0.054 | 0.067 | Elastase 1 inhibitor | 0.062 0.059 DBMET03220 0.067 0.051 DBMET03227 0.064 0.056 DBMET03221 | DBMET03227 | |
| 0.032 | 0.025 | 0.13 | Estrogen receptor alpha agonist | 0.069 0.014 DBMET03224 0.093 0.01 DBMET03227 0.077 0.012 DBMET03221 0.049 0.018 DBMET03222 0.13 0.006 DBMET03226 0.105 0.008 DBMET03223 | DBMET03226 | |
| 0.121 | 0.12 | 0.161 | Growth hormone agonist | 0.131 0.106 DBMET03220 0.15 0.087 DBMET03227 0.161 0.079 DBMET03221 | DBMET03221 | |
| 0.075 | 0.076 | 0.106 | Alpha adrenoreceptor antagonist | 0.081 0.071 DBMET03220 0.099 0.057 DBMET03224 0.106 0.053 DBMET03222 0.076 0.075 DBMET03223 | DBMET03222 | |
| 0.041 | 0.042 | 0.048 | Adenylate cyclase 1 inhibitor | 0.048 0.029 DBMET03227 0.045 0.033 DBMET03221 | DBMET03227 | |
| 0.062 | 0.065 | 0.095 | Alpha 1 adrenoreceptor antagonist | 0.066 0.062 DBMET03220 0.089 0.048 DBMET03224 0.095 0.045 DBMET03222 | DBMET03222 | |
| 0.08 | 0.083 | 0.087 | Thioredoxin inhibitor | 0.081 0.08 DBMET03220 0.087 0.068 DBMET03227 0.087 0.066 DBMET03221 | DBMET03221 | |
| 0.141 | 0.146 | 0.158 | Insulin sensitizer | 0.158 0.123 DBMET03227 | DBMET03227 | |
| 0.131 | 0.137 | 0.147 | Lipocortins synthesis antagonist | 0.147 0.109 DBMET03227 0.141 0.119 DBMET03221 | DBMET03227 | |
| 0.075 | 0.085 | 0.094 | Estrogen-related receptor beta agonist | 0.094 0.033 DBMET03227 0.083 0.059 DBMET03226 | DBMET03227 | |
| 0.044 | 0.053 | 0.052 | Sodium/calcium exchanger inhibitor | 0.052 0.03 DBMET03224 0.046 0.045 DBMET03222 0.05 0.034 DBMET03226 | DBMET03224 | |
| 0.013 | 0.027 | 0.016 | Antibiotic Tetracycline-like | 0.015 0.013 DBMET03224 0.016 0.008 DBMET03226 | DBMET03226 | |
| 0.079 | 0.11 | 0.116 | Topoisomerase II inhibitor | 0.114 0.073 DBMET03227 0.116 0.071 DBMET03226 | DBMET03226 | |
| 0.054 | 0.085 | 0.086 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.086 0.046 DBMET03227 | DBMET03227 | |
| 0.029 | 0.059 | 0.082 | Estrogen agonist | 0.079 0.023 DBMET03227 0.061 0.03 DBMET03221 0.082 0.022 DBMET03226 0.062 0.029 DBMET03223 | DBMET03226 | |
| 0.081 | 0.117 | 0.102 | Cholesterol synthesis inhibitor | 0.102 0.085 DBMET03227 | DBMET03227 | |
| 0.01 | 0.048 | 0.12 | Estrogen receptor beta agonist | 0.029 0.024 DBMET03224 0.073 0.015 DBMET03227 0.038 0.022 DBMET03221 0.12 0.009 DBMET03226 0.085 0.014 DBMET03223 | DBMET03226 | |
| 0.102 | 0.14 | 0.228 | Protein-tyrosine phosphatase inhibitor | 0.194 0.049 DBMET03224 0.134 0.096 DBMET03227 0.122 0.112 DBMET03221 0.175 0.059 DBMET03222 0.228 0.037 DBMET03226 0.201 0.046 DBMET03223 | DBMET03226 | |
| 0.023 | 0.065 | 0.043 | GP IIb/IIIa receptor antagonist | 0.043 0.039 DBMET03226 0.043 0.039 DBMET03223 | DBMET03223 | |
| 0.214 | 0.256 | 0.272 | Cyclophilin D inhibitor | 0.272 0.189 DBMET03227 0.272 0.188 DBMET03221 0.255 0.207 DBMET03226 0.256 0.206 DBMET03223 | DBMET03221 | |
| 0.021 | 0.073 | 0.042 | Sigma receptor antagonist | 0.042 0.039 DBMET03226 | DBMET03226 | |
| 0.135 | 0.194 | 0.157 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.133 DBMET03227 | DBMET03227 | |
| 0.124 | 0.186 | 0.187 | Free radical scavenger | 0.187 0.108 DBMET03227 0.181 0.114 DBMET03221 0.154 0.14 DBMET03226 0.149 0.146 DBMET03223 | DBMET03227 | |
| 0.181 | 0.244 | 0.28 | Calcium channel activator | 0.28 0.112 DBMET03220 0.227 0.175 DBMET03221 0.232 0.169 DBMET03222 | DBMET03220 | |
| 0.167 | 0.235 | 0.2 | Apoptosis antagonist | 0.2 0.179 DBMET03227 | DBMET03227 | |
| 0.039 | 0.113 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.041 DBMET03221 0.059 0.056 DBMET03223 | DBMET03221 | |
| 0.026 | 0.104 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET03223 | DBMET03223 | |
| 0.055 | 0.135 | 0.137 | Estrogen receptor alpha antagonist | 0.096 0.03 DBMET03224 0.084 0.043 DBMET03227 0.137 0.014 DBMET03226 0.091 0.034 DBMET03223 | DBMET03226 | |
| 0.021 | 0.104 | 0.062 | Alpha 1d adrenoreceptor antagonist | 0.055 0.045 DBMET03224 0.062 0.039 DBMET03222 | DBMET03222 | |
| 0.089 | 0.184 | 0.112 | DNA repair enzyme inhibitor | 0.112 0.091 DBMET03222 0.108 0.102 DBMET03223 | DBMET03222 | |
| 0.069 | 0.176 | 0.116 | Lipid peroxidase inhibitor | 0.116 0.098 DBMET03227 0.108 0.107 DBMET03221 | DBMET03227 | |
| 0.054 | 0.17 | 0.096 | Chelator | 0.096 0.084 DBMET03227 0.095 0.085 DBMET03221 | DBMET03227 | |
| 0.115 | 0.232 | 0.146 | Heat shock protein 70 antagonist | 0.14 0.076 DBMET03224 0.139 0.08 DBMET03222 0.146 0.057 DBMET03226 0.144 0.06 DBMET03223 | DBMET03226 | |
| 0.023 | 0.143 | 0.073 | Alpha 1b adrenoreceptor antagonist | 0.073 0.051 DBMET03222 | DBMET03222 | |
| 0.16 | 0.282 | 0.285 | Antibacterial | 0.27 0.159 DBMET03227 0.285 0.147 DBMET03221 0.226 0.2 DBMET03223 | DBMET03221 | |
| 0.055 | 0.187 | 0.107 | Adenylate cyclase inhibitor | 0.103 0.081 DBMET03227 0.107 0.078 DBMET03221 | DBMET03221 | |
| 0.067 | 0.224 | 0.131 | Anticoagulant | 0.129 0.102 DBMET03226 0.131 0.099 DBMET03223 | DBMET03223 | |
| 0.096 | 0.262 | 0.158 | Antioxidant | 0.158 0.156 DBMET03227 | DBMET03227 | |
| 0.056 | 0.226 | 0.167 | Toll-Like receptor 3 antagonist | 0.158 0.012 DBMET03220 0.129 0.023 DBMET03221 0.167 0.01 DBMET03222 0.153 0.014 DBMET03223 | DBMET03222 | |
| 0.109 | 0.284 | 0.189 | 12-Lipoxygenase inhibitor | 0.189 0.164 DBMET03226 | DBMET03226 | |
| 0.033 | 0.213 | 0.109 | Histamine N-methyltransferase inhibitor | 0.109 0.038 DBMET03226 | DBMET03226 | |
| 0.107 | 0.319 | 0.219 | Alpha-glucosidase inhibitor | 0.219 0.207 DBMET03223 | DBMET03223 | |
| 0.044 | 0.269 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.073 DBMET03226 0.097 0.06 DBMET03223 | DBMET03223 | |
| 0.115 | 0.345 | 0.212 | Sodium/bile acid cotransporter inhibitor | 0.199 0.189 DBMET03221 0.212 0.172 DBMET03223 | DBMET03223 | |
| 0.019 | 0.249 | 0.127 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 DBMET03227 0.095 0.028 DBMET03221 0.084 0.034 DBMET03226 0.127 0.016 DBMET03223 | DBMET03223 | |
| 0.099 | 0.437 | 0.231 | Peptidyltransferase inhibitor | 0.201 0.097 DBMET03221 0.201 0.097 DBMET03222 0.164 0.159 DBMET03226 0.231 0.066 DBMET03223 | DBMET03223 | |
| 0.125 | 0.487 | 0.476 | Calcium channel L-type activator | 0.408 0.076 DBMET03220 0.458 0.047 DBMET03221 0.441 0.056 DBMET03222 0.476 0.038 DBMET03223 | DBMET03223 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |